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Abstract (343 words) 13 
Background: Intestinal schistosomiasis was not considered endemic in Lake Malawi until 14 
November 2017 when populations of Biomphalaria pfeifferi were first reported; in May 15 
2018, emergence of intestinal schistosomiasis was confirmed. This emergence was in spite of 16 
ongoing control of urogenital schistosomiasis by preventive chemotherapy. Our current study 17 
sought to ascertain whether intestinal schistosomiasis is transitioning from emergence to 18 
outbreak, to judge if stepped-up control interventions are needed. 19 
Methods: During late-May 2019, three cross-sectional surveys of primary school children for 20 
schistosomiasis were conducted using a combination of rapid diagnostic tests, parasitological 21 
examinations and applied morbidity-markers; 1) schistosomiasis dynamics were assessed at 22 
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Samama (n = 80) and Mchoka (n = 80) schools, where Schistosoma mansoni was first 23 
reported, 2) occurrence of S. mansoni was investigated at two non-sampled schools, 24 
Mangochi Orphan Education and Training (MOET) (n = 60) and Koche (n = 60) schools, 25 
where B. pfeifferi was nearby, and 3) rapid mapping of schistosomiasis, and B. pfeifferi, 26 
conducted across a further 8 shoreline schools (n = 240). After data collection, univariate 27 
analyses and Chi-square testing were performed, followed by binary logistic regression using 28 
generalized linear models, to investigate epidemiological associations. 29 
Results: In total, 520 children from 12 lakeshore primary schools were examined, mean 30 
prevalence of S. mansoni by ‘positive’ urine circulating cathodic antigen (CCA)-dipsticks 31 
was 31.5% (95% Confidence Interval (CI): 27.5–35.5). Upon comparisons of infection 32 
prevalence in May 2018, significant increases at Samama (Relative Risk (RR) = 1.7, 95% CI: 33 
1.4–2.2) and Mchoka (RR = 2.7, 95% CI: 1.7–4.3) schools were observed. Intestinal 34 
schistosomiasis was confirmed at MOET (18.3%) and Koche (35.0%) schools, and in all 35 
rapid mapping schools, ranging from 10.0% to 56.7%. Several populations of B. pfeifferi 36 
were confirmed, with two new eastern shoreline locations noted. Mean prevalence of 37 
urogenital schistosomiasis was 24.0% (95% CI: 20.3–27.7).  38 
Conclusions: We notify that intestinal schistosomiasis, once considered non-endemic in 39 
Lake Malawi, is now transitioning from emergence to outbreak. Once control interventions 40 
can resume after coronavirus disease 2019 (COVID-19) suspensions, we recommend 41 
stepped-up preventive chemotherapy, with increased community-access to treatments, 42 
alongside renewed efforts in appropriate environmental control.  43 
 44 
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 47 
Background 48 
Lake Malawi is the world’s fourth largest freshwater lake, an important aquatic hotspot of 49 
global biodiversity but with urogenital schistosomiasis being endemic along many parts of its 50 
shoreline [1]. In Mangochi District, Malawi, the prevalence of Schistosoma haematobium 51 
infection in school children warrants preventive chemotherapy. This is achieved by annual 52 
mass drug administration (MDA) of praziquantel [2] as provided by the Malawi National 53 
Schistosomiasis and Soil-Transmitted Helminthiasis Control Programme 54 
(https://www.health.gov.mw/index.php/schistosomiasis-sth-control-programme). MDA is typically guided 55 
upon country-wide mapping information which is usually developed from inspection of five 56 
schools per district [3]. By contrast, intestinal schistosomiasis, caused by Schistosoma 57 
mansoni, is not considered endemic within the lake, as being congruent with the absence of 58 
Biomphalaria pfeifferi, an obligatory intermediate snail host and keystone snail species for 59 
parasite transmission [1,4,5].  60 
This appraisal was revised in May 2018 as, since November 2017 B. pfeifferi has been 61 
repeatedly encountered in the lake, alongside emergence of intestinal schistosomiasis 62 
documented in three local primary schools [6]. Prevalence of infection by ‘trace/positive’ 63 
urine circulating cathodic antigen (CCA)-dipsticks was 34.3% (95% CI: 27.9–41.3), with 64 
ova-patent S. mansoni in stool noted at Samama and Mchoka schools [6]. Even with ongoing 65 
annual MDA for urogenital schistosomiasis control, the dynamics of intestinal 66 
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schistosomiasis need further scrutiny here, for this disease could transition from emergence to 67 
outbreak.  68 
Transitions from emergence to outbreak are often driven by expansions in the 69 
distributions of intermediate snail hosts which, like elsewhere in Africa, can instigate, for 70 
example, new transmission foci [7]. Even though an outbreak terminology is rather vaguely 71 
defined, common with the epidemiology of other water-borne diseases [8], it is more so for 72 
schistosomiasis as its transmission dynamics also involve unsafe water contact, with per-73 
cutaneous (and oral) entry and infection routes. However, the use of outbreak vernacular can 74 
be appropriate, foremost, to spur commensurate public health actions, for example in 75 
stepped-up surveillance for the intermediate hosts or with intensified control interventions. 76 
This was evidenced in Senegal for intestinal schistosomiasis [9] and more recently in Corsica 77 
for urogenital schistosomiasis [10] which were each urged by the use of outbreak 78 
terminologies.  79 
To seek an appropriate public health response here on the shoreline of Lake Malawi, 80 
our investigation had three linked objectives: 1) to resample Samama and Mchoka schools, 81 
ascertaining the dynamics of schistosomiasis infection and morbidity after annual MDA, 2) to 82 
confirm intestinal schistosomiasis, also noting faecal occult blood (FOB), at two previously 83 
non-sampled schools, Mangochi Orphan Education and Training (MOET) and Koche 84 
schools, where in 2018 B. pfeifferi was found nearby and 3) to conduct a wider rapid mapping 85 
survey for schistosomiasis at eight further schools (St Augustine II, Ndembo, Chikomwe, 86 
Chipeleka, Sungusya, St Martins, Makumba and Mtengeza) to judge if an outbreak of 87 
intestinal schistosomiasis was occurring. 88 
Methods 89 
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Study design and sample size determination for each objective  90 
A cross-sectional study design was used to achieve the three study objectives, see STROBE 91 
checklist within supplemental materials. Based on previous epidemiological information [6], 92 
a sample size calculation with single population proportion formula 93 
(http://www.raosoft.com/samplesize.html) showed that a total sample size of 520 was 94 
sufficient to estimate overall prevalence of intestinal and urogenital schistosomiasis with < ± 95 
5% precision and 95% confidence. 96 
Based on prevalence data provided by the authors of the May 2018 study [6], a 97 
Fisher’s exact test was used to show that sampling of 80 children from each of Samama and 98 
Mchoka schools in June 2019 was sufficient to detect a 25-percentage-point rise in 99 
prevalence of each Schistosoma species at each school ( < 0.05,  < 0.20) (objective 1). To 100 
ensure detection of S. mansoni if present at MOET and Koche schools (objective 2), 60 101 
children were sampled from each. For objective 3, according to WHO (World Health 102 
Organisation) recommendations for rapid mapping, 30 children per school were sampled per 103 
school [11]. Random sampling was used at each school following stratification by age and 104 
gender. A study flow diagram is included (see Figure 1). 105 
 106 
<please insert Figure 1 near here> 107 
 108 
Study area 109 
At each school, global position system (GPS) coordinates were taken using an Oregon 650 110 
receiver (Garmin, Olathe, Kansas, USA). The GPS locations for each school in decimal 111 
degrees are as follows: Samama (-14.417465o, 35.217580o), Mchoka (-14.439481o, 112 
35.220644o), MOET (-14.320776o, 35.131558 o), Koche (-14.330917o, 35.146186o), St 113 
Augustine II (-14.473926o, 35.279613o), Ndembo (-14.456385o, 35.273794o), Chikomwe (-114 
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14.422136o, 35.265088o), Chipeleka (-14.385387o, 35.292935o), Sungusya (-14.386472o, 115 
35.311398o), St Martins (-14.351401o, 35.294435o), Makumba (-14.319806o, 35.286104o) 116 
and Mtengeza (-14.288932o, 35.264073o). A location map of the 12 schools is shown (see 117 
Figure 2).  118 
 119 
<please insert Figure 2 near here> 120 
 121 
Inclusion/exclusion criteria, diagnostics and praziquantel treatment of participants  122 
The surveys took place during late May/June 2019; after obtaining written informed parental 123 
consent for each child, a total of 520 children, aged 6–15, of balanced gender, were enrolled. 124 
Children not attending school and acutely unwell children were excluded. Participants could 125 
withdraw consent at any point. On the appointed day of survey, each school child provided a 126 
mid-morning urine sample and when requested, a stool sample, alongside undertaking a brief 127 
interview by questionnaire documenting place of birth, recent travel, water-contact habits and 128 
praziquantel treatment history. If found infected, upon ova patent infection or ‘trace/positive’ 129 
urine CCA-dipstick test, each child was provided with praziquantel (IDA Foundation, 130 
Amsterdam, The Netherlands) at 40 mg/kg.  131 
For detection of intestinal schistosomiasis, two drops of urine were applied to a CCA-132 
dipstick (Rapid Medical Diagnostics, Pretoria, South Africa). Results were scored visually 133 
against a reference colour photograph as ‘negative’, ‘trace’ or ‘positive’ and cross-checked 134 
[12]. To augment urine CCA-dipsticks, on-site inspection of collected stool was performed 135 
with parasitological methods; at Mchoka, Samama, MOET and Koche schools, all children 136 
were asked to provide a stool sample with a total of 265 specimens obtained (see Table 1). 137 
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Following our rapid mapping protocol at 8 remaining schools, stool was only requested from 138 
urine CCA-dipstick ‘positive’ children, obtaining 70 specimens (see Table 1).  139 
To visualize helminth ova in stool, individual specimens were filtered across a 212 140 
µm metal mesh then applied to produce duplicate thick (41.7 mg) Kato-Katz [11] smears as 141 
examined for lateral spine S. mansoni ova by microscopy (× 100). Intensity of S. mansoni 142 
infection as eggs per gram (epg) was classified as: light (1–99 epg), medium (100–399 epg) 143 
and heavy (≥ 400 epg) according to WHO guidelines [11]. To assess putative pathology 144 
associated with intestinal schistosomiasis [5], stools were screened for FOB using 145 
ALLTEST® cassettes (Access Diagnostic Tests UK Ltd, Aylsham, UK).  146 
For detection of urogenital schistosomiasis, 10 ml of well-mixed urine was filtered by 147 
syringe across a circular nylon mesh of 1.5 cm diameter, with 20 µm pore size (Plastok® 148 
[Meshes and Filtration] Ltd, Birkenhead, UK). The mesh was stained with Lugol’s iodine, 149 
then inspected by microscopy (× 100) to count terminal spine S. haematobium ova. Infection 150 
intensity was classified as light (< 50 ova per 10 ml) or heavy (≥ 50 ova per 10 ml) according 151 
to WHO guidelines [11]. Putative pathology associated with urogenital schistosomiasis was 152 
assessed by Siemens Multistix® 10 SG reagent strips (Medisave UK Ltd, Weymouth, UK) 153 
for microhematuria [5]. 154 
 155 
Malacological surveillance  156 
During May/June 2019, all known locations where B. pfeifferi was found were re-surveyed, 157 
alongside several new locations as visited on the eastern shoreline of the lake, based upon 158 
convenience sampling from in-field observations of human water contact. At each site, two 159 
collectors searched, for 20 minutes, for B. pfeifferi by hand and with metal sieves. GPS 160 
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coordinates, altitude and location photographs were taken with an Oregon 650 receiver 161 
(Garmin, Olathe, Kansas, USA). Water temperature (oC), pH and conductivity (µS) were 162 
recorded with a HI-98129 Pocket EC/TDS and pH Tester (Hanna Instruments Ltd, Leighton 163 
Buzzard, Bedfordshire, UK). Collected snails were kept for a week and screened daily for 164 
shedding S. mansoni cercariae by exposure to sunlight under a dissecting microscope (× 20). 165 
 166 
Data analyses  167 
Demographic, questionnaire and diagnostic data were tabulated with statistical analysis 168 
carried out using IBM SPSS® Version 24 (IBM, Portsmouth, UK). Univariate analyses and 169 
Chi-square testing were first performed, then binary logistic regression undertaken, 170 
calculating adjusted odds ratios with generalised linear models, with stepwise subtraction of 171 
variables, to investigate (un)adjusted epidemiological associations. 172 
 173 
Results 174 
Prevalence and distribution of intestinal and urogenital schistosomiasis 175 
The outline map, Figure 2, is a summary of all information obtained from urine CCA-176 
dipsticks with the distribution of intestinal schistosomiasis displayed. When ‘trace’ was 177 
considered infected, mean prevalence was 82.5%. When ‘trace’ was considered not infected, 178 
this declined to 31.5%. Common across all school children were very high levels of reported 179 
weekly water contact (> 75%), inclusive of bathing, swimming and drinking. The known 180 
distribution of B. pfeifferi along the western shoreline, alongside new reports on the eastern 181 
shoreline in December 2018 and May/June 2019, is shown. In locations where B. pfeifferi 182 
was found, water parameters ranged: pH 7.5–8.5, temperature 21.5–26.2 oC, conductivity 183 
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312–458 µS and total dissolved salts 155–244 ppm; no collected snail (n = 52) was observed 184 
to shed S. mansoni cercariae. 185 
 186 
<please insert Table 1 near here> 187 
 188 
Ova-patent S. mansoni infections, including both medium and heavy intensity 189 
infections, were observed (see Table 1). Ova patent urogenital schistosomiasis was detected 190 
in all schools, ranging from 1.7% to 60.0%, inclusive of heavy intensity infections, except at 191 
Koche, St Martins and Makumba schools. Across our sample, 75 (14.4%) children were 192 
considered ‘free’ from schistosomiasis; if urine CCA-dipstick ‘trace’ was considered infected 193 
or ‘trace’ was considered not infected, then 109 (36.5%) or 56 (10.7%) children were judged 194 
co-infected with intestinal and urogenital schistosomiasis, respectively.  195 
 196 
<please insert Figure 3 near here> 197 
 198 
Risk factors associated with schistosomiasis-associated morbidity  199 
Significant increases of schistosomiasis at Mchoka and Samama were observed (see Figure 3) 200 
even though MDA treatment coverage (81.9%), as reported by interview, was good. Relative 201 
risk of infection prevalence of S. mansoni significantly increased at Samama (RR = 1.7, 95% 202 
CI: 1.4–2.2]) and Mchoka (RR = 2.7, 95% CI: 1.7–4.3) schools, indicative of substantive re-203 
infection concurrent with increasing environmental transmission for both types of 204 
schistosomiasis.  205 
 206 
<please insert Table 2 near here> 207 
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Analysis of risk factors associated with schistosomiasis-associated morbidity (see 208 
Table 2) showed that ‘positive’ urine CCA-dipstick results and ova-patent S. mansoni were 209 
significantly associated with FOB, alongside ova-patent S. haematobium with 210 
microhaematuria. Neither age nor gender were associated with these morbidity indicators 211 
although a marginal protective effect of MDA, on both FOB and microhaematuria, was 212 
observed.  213 
Discussion 214 
Our integrated surveillance approach was unified by three linked cross-sectional surveys, see 215 
Figure 1, and a conjoined malacological inspection. Collectively this builds a more thorough 216 
assessment of the changing epidemiology of intestinal and urogenital schistosomiasis on the 217 
Lake Malawi shoreline (see Figure 2 and Table 1). Of note, is that the prevalence of both forms 218 
of schistosomiasis is increasing (see Figure 3), indicative perhaps that the force of infection 219 
[13] for each parasite is rising, with intestinal schistosomiasis being of newest public health 220 
concern here.  221 
Our study detected a mean prevalence of intestinal schistosomiasis by ‘positive’ urine 222 
CCA-dipstick results of 31.5% (95% CI: 27.5–35.5). Notably, significant increases in infection 223 
prevalence since May 2018 were observed at Samama (RR = 1.7, 95% CI: 1.4–2.2) and 224 
Mchoka (RR = 2.7, 95% CI: 1.7–4.3) schools. The disease was also confirmed at MOET 225 
(18.3%) and Koche (35.0%) schools with a broader geographical footprint apparent across the 226 
8 rapid mapping schools, with prevalence ranging from 10.0% to 56.7%, and several extant 227 
populations of B. pfeifferi were confirmed on the eastern and western lake shoreline. 228 
Concurrently mean prevalence of urogenital schistosomiasis was 24.0% (95% CI: 20.3–27.7) 229 
with 109 (36.5%) or 56 (10.7%) children co-infected with intestinal schistosomiasis, as 230 
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contingent upon interpretation of urine-CCA dipstick ‘trace’ as infection-positive or negative, 231 
respectively. 232 
The unexpected occurrence of intestinal schistosomiasis elsewhere in Malawi, 233 
alongside the more well-known urogenital schistosomiasis, has been encountered before; the 234 
surveys conducted by Poole et al. in Chikhwawa during June 2012 noted that 24.9% and 9.1% 235 
of mothers and their pre-school-aged children were positive by urine CCA-dipsticks with ova-236 
patent S. mansoni infections confirmed [14]. While Biomphalaria was not detected in their 237 
search for local snails [14], the occurrence of B. pfeifferi, as shown here in Figure 2, adds 238 
weight to their postulate of intermittent transmission of S. mansoni in Chikhwawa. They 239 
suggested that the occasional influx of upstream populations of B. pfeifferi in the Shire River, 240 
as being swept downstream during seasonal flooding, might then colonize temporary pools in 241 
the Lower Shire River flood plain, to spark sporadic transmission in Chikhwawa [14]. By 242 
contrast, an enduring presence of B. pfeifferi along Lake Malawi and Upper Shire River, gives 243 
rise to more sustained opportunities in local transmission of S. mansoni in Mangochi District.   244 
In regard of this lake shoreline setting, we have shown 1) increases in the prevalence 245 
of intestinal schistosomiasis at Mchoka and Samama Schools, 2) occurrence of intestinal 246 
schistosomiasis at MOET and Koche schools and 3) endemic intestinal schistosomiasis 247 
occurring along a 80 km section of Lake Malawi and Shire River shoreline, noting additional 248 
populations of B. pfeifferi on the lake’s eastern shoreline (see Figure 2). Of particular note is 249 
the strong association of S. mansoni infection, as detected by urine CCA-dipsticks, with FOB 250 
in 16.2% of examined children, see Table 2, indicative of overt intestinal pathology [15]. 251 
Combined with the observations of ova-patent infections of moderate- and heavy-intensities at 252 
Koche and Ndembo, as well as, ova-patent infections at a further five schools, this is pervasive 253 
evidence of more sustained local transmission of intestinal schistosomiasis.  254 
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Whilst the debate on how to interpret ‘trace’ reactions of urine-CCA dipsticks 255 
continues, a ‘positive’ reaction is considered solid evidence of active intestinal schistosomiasis 256 
[12]. With no association detected between urogenital schistosomiasis and urine-CCA in our 257 
study, we conclude that urine-CCA tests are highly specific for S. mansoni detection, with 258 
‘trace’ results indicating light sub-clinical infections, with sub-patent egg outputs. Therefore, 259 
31.5% (95% CI: 27.5–35.5) of our sampled children were suffering from intestinal 260 
schistosomiasis but if a ‘trace’ reaction was considered diseased then a total of 82.5% (95% 261 
CI: 79.2–85.8] were infected or, at the very least, at-risk. Of particular note in this light is 262 
intestinal schistosomiasis at Ndembo and St Augustine II schools, see Figure 2, where the 263 
prevalence of ‘positive’ urine-CCA dipsticks was > 50% and ova-patent S. mansoni infections 264 
were encountered, being of light and moderate infection intensities, Table 1; moreover, 265 
moderate and heavy ova-patent S. mansoni infections were detected at Koche school where the 266 
prevalence of ‘positive’ urine-CCA dipsticks was 35.0%, with B. pfeifferi found nearby.  267 
Our rapid disease mapping surveillance across eight schools, currently augments 268 
district-level information of the national control programme, critically revising scientific 269 
appraisals concerning the previous absence of intestinal schistosomiasis [1], and better 270 
demonstrates the newly defined endemicity of intestinal schistosomiasis along the Mangochi 271 
District shoreline. When taken as a whole, we judge that there is now sufficient evidence to 272 
notify that an outbreak of intestinal schistosomiasis is occurring. This has immediate bearing 273 
on the health of the local populace and tourists who may visit here, as well as, in health advice 274 
or diagnostic testing undertaken in local or international medical clinics presently unaware of 275 
this new risk of intestinal schistosomiasis.  276 
 277 
<please insert Figure 4 near here> 278 
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In terms of environmental surveillance, it is worthy to note that the lake is undergoing 279 
ecological change, most easily seen with lake level changes through time, see Figure 4. Its 280 
dynamic shoreline and lake level are manifest, perhaps creating new habitats for B. pfeifferi to 281 
colonize and or were facilitating collection of this snail in locations previously too deep to be 282 
retrieved by hand. The dispersion of this snail, a keystone species for S. mansoni, like in 283 
Senegal [9] or in Ethiopia [7], is a critical epidemiological driver of intestinal schistosomiasis 284 
transmission.  285 
Control of schistosomiasis needs a multisectoral approach and it is often debated how 286 
control tactics should be changed [16] or better tailored to aquatic environments [17]. To 287 
respond to this outbreak of intestinal schistosomiasis, we propose that current MDA efforts 288 
should be intensified, adopting biannual treatment cycles in schools, which has been 289 
successfully implemented elsewhere [18], alongside expanded access to praziquantel for all 290 
community members with intestinal schistosomiasis, in need of regular treatment throughout 291 
the year [19]. From recent surveys of adult fishermen who have urogenital schistosomiasis, 292 
making specific reference to male genital schistosomiasis, co-infection with S. mansoni has 293 
been noted alongside re-infections within a calendar year [20, 21]. To augment MDA and 294 
community-access to praziquantel, it is important to strengthen health education and outreach 295 
with suitable water, sanitation and hygiene (WASH) interventions [20, 22], better appropriate 296 
to this lakeshore setting, noting that even focal application of molluscicides is inappropriate 297 
[17], given this lake’s global importance in biodiversity.  298 
A significant limitation of our study was the exclusion of certain demographic groups 299 
in our survey. This included pre-school-aged and out-of-school children, as well as, more 300 
vulnerable adults [23]. However, with increased future resourcing inspection of these groups 301 
is important to better assess how they are each afflicted by this outbreak. To do so, we 302 
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recommend a combination of both rapid urine and faecal sampling methods with inspection of 303 
a more extensive range of point-of-contact morbidity markers to provide a better insight into 304 
individual disease progression(s) [24]. Future use of 20 m shuttle-run tests to assess children’s 305 
aerobic capacity in relation to S. mansoni infection could be insightful, as recently shown 306 
elsewhere [25]. However, with coronavirus disease 2019 (COVID-19) suspending annual 307 
MDA, we should expect and better prepare for increasing severity of intestinal schistosomiasis 308 
in following years.  309 
Conclusions 310 
Our three main study objectives were achieved: demonstration of increasing prevalence of 311 
intestinal and urogenital schistosomiasis at Samama and Mchoka schools, newly confirmed 312 
intestinal schistosomiasis at previously non-sampled schools near reported B. pfeifferi sites 313 
(MOET and Koche schools), and detection of intestinal schistosomiasis at a further eight 314 
sampled schools along the shoreline. Despite ongoing annual MDA of praziquantel for 315 
urogenital schistosomiasis, we conclude that an outbreak of intestinal schistosomiasis is 316 
occurring in Mangochi District, Malawi. Increased vigilance for B. pfeifferi, especially along 317 
the lake’s eastern shores and in downstream locations on the Shire River, is needed with 318 
additional epidemiological inspections of adjacent schools and communities to better gauge the 319 
full footprint of intestinal schistosomiasis. Due to the COVID-19 pandemic, this outbreak will 320 
continue to expand unchecked, but once control activities can resume, we strongly recommend 321 
stepping-up MDA treatment cycles, i.e. from annual to biannual, increasing community access 322 
to praziquantel treatment throughout the year, with renewed efforts to mitigate environmental 323 
transmission with health education and appropriate WASH interventions.  324 
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Figure 1. A study flow-chart of the objectives, sample size and methods used during this 454 
investigation. 455 
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Figure 2. Schematic map showing the prevalence of intestinal schistosomiasis in June 2019, 457 
by sampled school, by urine CCA-dipsticks.  458 
Freshwater sites inspected for Biomphalaria pfeifferi over the November 2017–December 459 
2019 period are also shown [Note that schools denoted with a flag represent locations where 460 
ova-patent Schistosoma mansoni infection was observed, and the schools associated with 461 
objectives 1–3. The black arrow labelled ‘A’ denotes the bay area as shown in the Figure 4 462 
where the shoreline has changed during the 2005–2016 most likely due to lowering lake 463 
levels and local sedimentation, where numerous B. pfeifferi (n ≥ 10) have been consistently 464 
found]. +ve: positive; -ve: negative. 465 
 466 
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Figure 3. The year-on-year increase of prevalence of urogenital (by urine filtration) and 467 
intestinal (by ‘trace/positive’ urine CCA-dipsticks) schistosomiasis despite annual MDA 468 
across the two schools Mchoka and Samama as sampled in 2018 and 2019. Error bars 469 
indicate 95% confidence intervals.  470 
 471 
 472 
 473 
 474 
 475 
 476 
 477 
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Figure 4a. Composite satellite map, modified from GoogleEarth imagery, that illustrates the 478 
changing shoreline of the lake in 2005, 2012, 2013 and 2016. The featured area is the bay 479 
indicated by the black arrow labelled ‘A’ in Figure 1. The green circle ‘M12’ denotes the 480 
sampling location where numerus Biomphalaria have been found during all malacological 481 
inspections from November 2017 to December 2019. The changing shoreline is most likely 482 
resultant from lowering lake levels, see 4B, as well as, upon influx of sediments from the 483 
seasonal river in the bottom part of this image.  484 
Figure 4b. Annual changes in the lake  surface levels during 1992–2019 period (see 485 
https://ipad.fas.usda.gov/cropexplorer/global_reservoir/gr_regional_chart.aspx?regionid = 486 
eafrica&reservoir_name = Malawi), as detected by remote altimetry, denoting two 487 
particularly low-level periods, in 1996–1998 and 2017–2019, which may help explain the 488 
changing shoreline shown in 4A as the lake recedes in depth. m MSL: meters above Mean 489 
Sea Level.  490 
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Table 1. Occurrence of ova-patent Schistosoma mansoni in stool and prevalence and 493 
intensity of S. haematobium infections by school.  494 
 495 
* unable to report prevalence due to selective stool sampling (8.1% of total stool collected was ova-patent; 15.7% 496 
of stool collected in selective sampling was ova-patent) 497 
 intensity by Kato-Katz: light: 1–99 epg; medium: 100–399 epg; heavy: ≥ 400 epg 498 
 intensity by urine filtration: light: < 50 ova per 10 ml; heavy: ≥50 ova per 10 ml 499 
- calculation not applicable 500 
 501 
 502 
School 
(sample size) 
Stool: Kato-Katz 
(S. mansoni) 
 
Urine: filtration 
(S. haematobium) 
 
Number 
of stool 
samples 
collected 
Prevalence 
(%) 
[95% CI] 
Infection intensity 
(eggs per gram) 
[% of positives] 
Prevalence 
(%) 
[95% CI] 
Infection intensity 
(eggs per 10 ml) 
[% of positives] 
Light 
 
Medium Heavy Light Heavy 
TOTAL 
(n = 520) 
335 * 20 
[74.1] 
4 
[14.8] 
3 
[11.1] 
24.0 
[20.3 – 27.7] 
80 
[64.0] 
45 
[36.0] 
 
All collected stools, irrespective of CCA status, were examined 
 
Mchoka 
(n = 80) 
73 1.4 
[0.0–4.1] 
1 
[100.0] 
0 
[0.0] 
0 
[0.0] 
18.8 
[10.2–27.4] 
11 
[73.3] 
4 
[26.7] 
Samama 
(n = 80) 
77 5.2 
[0.2–10.2] 
4 
[100.0] 
0 
[0.0] 
0 
[0.0] 
56.3 
[45.4–67.2] 
30 
[66.7] 
15 
[33.3] 
MOET 
(n = 60) 
56 3.6 
[0.0–8.5] 
2 
[100.0] 
0 
[0.0] 
0 
[0.0] 
8.3 
[1.3–15.3] 
3 
[60.0] 
2 
[40.0] 
Koche 
(n = 60) 
59 15.3 
[6.1–24.5] 
3 
[33.3] 
3 
[33.3] 
3 
[33.3] 
1.7 
[0.0–5.0] 
1 
[100.0] 
0 
[0.0] 
 
Only selective stools from urine-CCA ‘positive’ children were examined 
 
St Augustine II 
(n = 30) 
15 * 3 
[100.0] 
0 
[0.0] 
0 
[0.0] 
43.3 
[25.6–61.0] 
8 
[61.5] 
5 
[38.5] 
Ndembo 
(n = 30) 
15 * 6 
[85.7] 
1 
[14.3] 
0 
[0.0] 
60.0 
[42.5–77.5] 
7 
[38.9] 
11 
[61.1] 
Chikomwe 
(n = 30) 
10 * 0 
[-] 
0 
[-] 
0 
[-] 
10.0 
[0.0–20.7] 
1 
[33.3] 
2 
[66.7] 
Chipeleka 
(n = 30) 
3 * 0 
[-] 
0 
[-] 
0 
[-] 
26.7 
[10.9–42.5] 
4 
[50.0] 
4 
[50.0] 
Sungusya 
(n = 30) 
7 * 0 
[-] 
0 
[-] 
0 
[-] 
16.7 
[3.4–30.0] 
4 
[80.0] 
1 
[20.0] 
St Martins 
(n = 30) 
4 * 0 
[-] 
0 
[-] 
0 
[-] 
3.3 
[0.0–9.7] 
1 
[100.0] 
0 
[0.0] 
Makumba 
(n = 30) 
6 * 1 
[100.0] 
0 
[0.0] 
0 
[0.0] 
6.7 
[0.0–15.6] 
2 
[100.0] 
0 
[0.0] 
Mtengeza 
(n = 30) 
10 * 0 
[-] 
0 
[-] 
0 
[-] 
30.0 
[13.6–46.4] 
8 
[88.9] 
1 
[11.1] 
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Table 2. Risk factors analyses for morbidity associated with urogenital and intestinal 503 
schistosomiasis upon detection of microhematuria and FOB, respectively.  504 
α all total of 200 FOB tests were available being used at Samama, Mchoka and MOET schools 505 
 a trace result was considered here as not infected, only +ve urine CCA-dipstick scorings were considered 506 
infected; our conservative approach was based upon correlates of urine CCA-dipsticks and duplicate Kato-Katz 507 
comparisons, with ova-patent prevalence of S. mansoni being ≥ 20%, see Bärenbold et al. [12]. 508 
 509 
 Microhematuria 
 
FOB 
Prevalence (%) [95% CI] 
 
31.5 [27.5–35.5] 16.2 [11.0–21.4] 
Sample size n = 520 n = 191α 
 
 Unadjusted odds 
ratio 
(95% CI) 
[P-value] 
Adjusted odds 
ratio 
(95% CI) 
[P-value] 
Unadjusted odds 
ratio 
(95% CI) 
[P-value] 
Adjusted odds 
ratio 
(95% CI) 
[P-value] 
Urine-CCA test 
 
 
 
 
Negative 
 
1 1 1 1 
Positive 2.0 
(1.4–3.0) 
[<0.01] 
1.2 
(0.6–2.6) 
[0.61] 
12.9 
(4.3–38.7) 
[<0.01] 
9.2 
(3.0–28.6) 
[<0.01] 
Ova-patent 
intestinal 
schistosomiasis 
(Kato-Katz) 
Negative 1 
 
1 1 1 
Positive 2.2 
(1.0–4.7) 
[0.06] 
3.0 
(1.0–8.6) 
[0.04] 
11.4 
(3.9–33.3) 
[<0.01] 
6.7 
(2.0–22.6) 
[<0.01] 
Ova-patent 
urogenital 
schistosomiasis 
(urine filtration) 
Negative 1 
 
1 1 1 
Positive 42.1 
(23.2–76.5) 
[<0.01] 
47.9 
(22.6–101.5) 
[<0.01] 
1.6 
(0.7–3.8) 
[0.25] 
1.5 
(0.5–4.9) 
[0.49] 
Praziquantel 
treatment in last 12 
months 
No 1 
 
1 1 1 
Yes 0.7 
(0.5–1.1) 
[0.16] 
0.7 
(0.3–1.8) 
[0.45] 
0.5 
(0.2–1.3) 
[0.16] 
0.8 
(0.3–2.3) 
[0.65] 
Gender Male 1 
 
1 1 1 
Female 1.0 
(0.7–1.4) 
[0.85] 
0.9 
(0.5–1.8) 
[0.82] 
1.1 
(0.5–2.3) 
[1.00] 
1.0 
(0.4–2.4) 
[0.97] 
Age (years) 6–10 1 
 
1 1 1 
11–15 0.9 
(0.6–1.4) 
[0.71] 
1.2 
(0.6–2.3) 
[0.63] 
1.1 
(0.507–2.4) 
[0.81] 
0.9 
(0.3–2.3) 
[0.78] 
